+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study



Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study



European Journal of Clinical Pharmacology 68(12): 1667-1676



Although the prevalence of drug-drug interactions (DDIs) in elderly outpatients is high, many potential DDIs do not have any actual clinical effect, and data on the occurrence of DDI-related adverse drug reactions (ADRs) in elderly outpatients are scarce. This study aimed to determine the incidence and characteristics of DDI-related ADRs among elderly outpatients as well as the factors associated with these reactions. A prospective cohort study was conducted between 1 November 2010 and 31 November 2011 in the primary public health system of the Ourinhos micro-region, Brazil. Patients aged ≥60 years with at least one potential DDI were eligible for inclusion. Causality, severity, and preventability of the DDI-related ADRs were assessed independently by four clinicians using validated methods; data were analysed using descriptive analysis and multiple logistic regression. A total of 433 patients completed the study. The incidence of DDI-related ADRs was 6 % (n = 30). Warfarin was the most commonly involved drug (37 % cases), followed by acetylsalicylic acid (17 %), digoxin (17 %), and spironolactone (17 %). Gastrointestinal bleeding occurred in 37 % of the DDI-related ADR cases, followed by hyperkalemia (17 %) and myopathy (13 %). The multiple logistic regression showed that age ≥80 years [odds ratio (OR) 4.4; 95 % confidence interval (CI) 3.0-6.1, p < 0.01], a Charlson comorbidity index ≥4 (OR 1.3; 95 % CI 1.1-1.8, p < 0.01), consumption of five or more drugs (OR 2.7; 95 % CI 1.9-3.1, p < 0.01), and the use of warfarin (OR 1.7; 95 % CI1.1-1.9, p < 0.01) were associated with the occurrence of DDI-related ADRs. With regard to severity, approximately 37 % of the DDI-related ADRs detected in our cohort necessitated hospital admission. All DDI-related ADRs could have been avoided (87 % were ameliorable and 13 % were preventable). The incidence of ADRs not related to DDIs was 10 % (n = 44). The incidence of DDI-related ADRs in elderly outpatients is high; most events presented important clinical consequences and were preventable or ameliorable.

(PDF emailed within 0-6 h: $19.90)

Accession: 036442196

Download citation: RISBibTeXText

PMID: 22644345

DOI: 10.1007/s00228-012-1309-3


Related references

Incidence and predictors of adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study. Journal of Pharmacy and Pharmaceutical Sciences 15(2): 332-343, 2012

Association of adverse drug reactions with drug-drug and drug-disease interactions in frail older outpatients. Age and Ageing 40(2): 274-277, 2011

Prospective observational evaluation of incidences and implications of drug-drug interactions induced adverse drug reactions in critically ill patients. Indian Journal of Pharmaceutical Sciences 72(6): 787-792, 2011

Epidemiology and characteristics of adverse drug reactions caused by drug-drug interactions. Expert Opinion on Drug Safety 11(1): 83-94, 2012

Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study. Croatian Medical Journal 52(5): 604-614, 2012

Adverse drug reactions caused by drug-drug interactions reported to Croatian Agency for Medicinal Products and Medical Devices: a retrospective observational study. Croatian Medical Journal 52(5): 604-614, 2011

Adverse Drug reactions in an Ageing PopulaTion (ADAPT) study protocol: a cross-sectional and prospective cohort study of hospital admissions related to adverse drug reactions in older patients. BMJ Open 7(6): E017322, 2018

Discrepancies in reported drug use in geriatric outpatients: relevance to adverse events and drug-drug interactions. American Journal of Geriatric PharmacoTherapy 7(2): 93-104, 2009

Comparative analysis of three drug-drug interaction screening systems against probable clinically relevant drug-drug interactions: a prospective cohort study. European Journal of Clinical Pharmacology 73(7): 875-882, 2017

Drug therapy and adverse drug reactions to terbutaline in obstetric patients: a prospective cohort study in hospitalized women. Bmc Pregnancy and Childbirth 2(1): 3, 2002

Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. Plos One 9(11): E112133, 2015

Genetic variants of drug metabolizing enzymes and drug transporter (ABCB1) as possible biomarkers for adverse drug reactions in an HIV/AIDS cohort in Zimbabwe. Current HIV Research 11(6): 481-490, 2014

A 6-year retrospective study of adverse drug reactions due to drug-drug interactions between nervous system drugs. International Journal of Clinical Pharmacology and Therapeutics 52(5): 392-401, 2014

Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods. Artificial Intelligence in Medicine 48(2-3): 161-166, 2010

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Revista Latino-Americana de Enfermagem 24: E2800, 2017